A case of infliximab-related liver damage - Case report and literature review

Journal of Japanese Society of Gastroenterology

Volumn 110, Issue 1, 2013, Pages 104-111

  Arai, Osamu ^a   Omoto, Kenji ^a   Notohara, Kenji ^b   Shibata, Norikuni ^a   Kuboki, Makoto ^a   Ikeda, Hiroshi ^a  

^a University of Tokyo   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ARTHRALGIA; ARTICLE; AUTOIMMUNE HEPATITIS; BEHCET DISEASE; CASE REPORT; DIARRHEA; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; GENETIC PREDISPOSITION; HEPATITIS; HOSPITAL ADMISSION; HUMAN; LIVER BIOPSY; LIVER FUNCTION; LIVER INJURY; LIVER NECROSIS; PATIENT MONITORING; STEROID THERAPY; VISUAL IMPAIRMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER FAILURE, ACUTE; MIDDLE AGED;

EID: 84873149118     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Menghini VV, Arora AS : Infliximab-associated reversible cholestatic liver disease. Mayo Clin Proc 76; 84-86 : 2001
2. Saleem G, Li SC, MacPherson BR, et al : Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy : comment on the article by Charles et al. Arthritis Rheum 44; 1966-1968 :2001
3. Germano V, Picchianti Diamanti A, Baccano G, et al : Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis 64; 1519-1520 : 2005
4. Tobon GJ, Cañas C, Jailer JJ, et al : Serious liver disease induced by infliximab. Clin Rheumatol 26;578-581 : 2007
5. Garcia Aparicio AM, Rey JR, Sanz AH, et al : Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab. Clin Rheumatol 26; 811-813 : 2007
6. Soto-Fernández S, González-Carro P, De Pedro Esteban A, et al : Infliximab-induced hepatitis in a patient with Crohn's disease. Gastroenterol Hepatol 29; 321-322 : 2006
7. Wahie S, Alexandroff A, Reynolds NJ : Hepatitis : a rare, but important complication of infliximab therapy for psoriasis. Clin Exp Dermatol 31; 460-461 : 2006
8. Ozorio G, McGarity B, Bak H, et al : Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis. Med J Aust 187; 524-526 : 2007
9. Ierardi E, Valle ND. Nacchiero MC, et al : Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis. Clin Drug Investig 26; 673-676 : 2006
10. Marques M, Magro F, Cardoso H, et al : Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis. Inflamm Bowel Dis 14; 723-725 : 2008
11. Becker H, Willeke P, Domschke W, et al : Etanercept tolerance in a patient with previous infliximab-induced hepatitis. Clin Rheumatol 27;1597-1598 : 2008
12. Thiéfin G, Morelet A, Heurgué A, et al : Infliximab-induced hepatitis : absence of cross-toxicity with etanercept. Joint Bone Spine 75;737-739 : 2008
13. Fairhurst DA, Sheehan-Dare R : Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis. Clin Exp Dermatol 34; 421-422 : 2009
14. Carlsen KM, Riis L, Madsen OR : Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept. Clin Rheumatol 28; 1001-1003 : 2009
15. Kluger N, Girard C, Guillot B, et al : Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis. Acta Derm Venereol 89; 332-334 : 2009
16. Mancini S, Amorotti E, Vecchio S, et al : Infliximab-related hepatitis : discussion of a case and review of the literature. Intern Emerg Med 5; 193-200 : 2010
17. Doyle A, Forbes G, Kontorinis N : hepatitis during infliximab therapy for Crohn's disease : a case report. J Crohns Colitis 5; 253-255 : 2011
18. Subramaniam K, Chitturi S, Brown M, et al : Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate. Inflamm Bowel Dis 17; E149-E150 :2011
19. Goldfeld DA, Verna EC, Lefkowitch J, et al : Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease : the index case. Dig Dis Sci 56; 3386-3388 : 2011
20. Cassani F, Bianchi FB, Lenzi M, et al : Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol 38;801-805 : 1985
21. Dufour JF, Zimmermann M, Reichen J : Severe autoimmune hepatitis in patients with previous spontaneous recovery of a flare. J Hepatol 37; 748-752 : 2002
22. Abe M, Hiasa Y, Masumoto T, et al : Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis. Hepatol Res 21; 213-219 : 2001
23. Eriksson C, Engstrand S, Sundqvist KG, et al : Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha. Ann Rheum Dis 64; 403-407 : 2005
24. Ferraro-Peyret C, Coury F, Tebib JG, et al : Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations : a two-year prospective study. Arthritis Res Ther 6; R535-R543 : 2004
25. Stratigos AJ, Antoniou C, Stamathioudaki S, et al : Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol 29; 150-153 : 2004
26. Tilg H, Kaser A, Moschen AR : How to modulate inflammatory cytokines in liver diseases. Liver Int 26; 1029-1039 : 2006